American College of Clinical Pharmacy
      Search      Cart
         

Nephrology PRN Focus Session -- Drug Dosing Considerations with Renal Replacement Therapy: Inpatient and Outpatient Settings

Monday, October 09, 2017 from 1:45 PM to 3:15 PM MST at Phoenix Convention Center North Building Street Level: Meeting Room 128

Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-17-150-L01-P
Activity Type: A Knowledge-Based Activity


Speakers
CRRT and SLED: Inpatient Dialysis Techniques and Their Impact on Drug Dosing
1:45 PM

Speakers
  • Joanna Q. Hudson, Pharm.D., FCCP, BCPSSpeaker: Joanna Q. Hudson, Pharm.D., FCCP, BCPS
    Professor, University of Tennessee, Departments of Clinical Pharmacy & Medicine (Nephrology), Memphis, Tennessee
      View Biography


Learning Objectives
1. Describe factors that alter pharmacokinetic parameters in patients receiving inpatient dialysis modalities.
2. Compare and contrast drug dosing considerations for inpatient dialysis therapies including intermittent hemodialysis and the various continuous renal replacement therapy techniques.
3. Discuss research evaluating pharmacokinetic alterations of medications using hybrid renal replacement therapies including slow low efficiency dialysis.
4. Apply alterations of pharmacokinetic parameters of medications used in inpatient dialysis modalities to understand strategies to attain pharmacodynamic targets in acute care settings.
Peritoneal, Home, and Nocturnal Dialysis: Outpatient Dialysis Techniques and Their Impact on Drug Dosing
2:30 PM

Speakers
  • Katie E. Cardone, FCCP, FNKF, FASN, BCACPSpeaker: Katie E. Cardone, FCCP, FNKF, FASN, BCACP
    Associate Professor, Albany College of Pharmacy and Health Sciences, Albany, New York
      View Biography


Learning Objectives
1. Describe factors that alter pharmacokinetic parameters in patients receiving outpatient dialysis modalities.
2. Compare and contrast drug dosing considerations for outpatient dialysis techniques including peritoneal dialysis, home dialysis and nocturnal dialysis.
3. Discuss literature and research evaluating pharmacokinetic alterations of medications using outpatient dialysis therapies.
4. Apply alterations of pharmacokinetic parameters of medications used in outpatient dialysis modalities to understand strategies to attain pharmacodynamic targets in these outpatient settings.